Education
About Us
Working with TipRanks
Follow Us
Palisade Bio (PALI)
NASDAQ:PALI
Total Valuation
Palisade Bio has a market cap or net worth of $3.07M. The enterprise value is $162.93M.
Market Cap$3.07M
Enterprise Value$162.93M
Share Statistics
Palisade Bio has 4,795,646 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,795,646
Owned by Insiders0.46%
Owned by Institutions3.63%
Financial Efficiency
Palisade Bio’s return on equity (ROE) is -1.93 and return on invested capital (ROIC) is -190.18%.
Return on Equity (ROE)-1.93
Return on Assets (ROA)-1.33
Return on Invested Capital (ROIC)-190.18%
Return on Capital Employed (ROCE)-1.94
Revenue Per Employee0.00
Profits Per Employee-1.80M
Employee Count8
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Palisade Bio is -0.66. Palisade Bio’s PEG ratio is 1.12.
PE Ratio-0.66
PS Ratio0.00
PB Ratio32.75
Price to Fair Value1.28
Price to FCF-23.14
Price to Operating Cash Flow-23.14
PEG Ratio1.12
Income Statement
In the last 12 months, Palisade Bio had revenue of 0.00 and earned -14.44M in profits. Earnings per share was -2.48.
Revenue0.00
Gross Profit0.00
Operating Income-14.86M
Pretax Income-14.44M
Net Income-14.44M
EBITDA-14.86M
Earnings Per Share (EPS)-2.48
Cash Flow
In the last 12 months, operating cash flow was -11.35M and capital expenditures 0.00, giving a free cash flow of -11.35M billion.
Operating Cash Flow-11.35M
Free Cash Flow-11.35M
Free Cash Flow per Share-2.37
Dividends & Yields
Palisade Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.22
52-Week Price Change-86.32%
50-Day Moving Average0.73
200-Day Moving Average1.82
Relative Strength Index (RSI)39.31
Average Volume (3m)527.68K
Important Dates
Palisade Bio upcoming earnings date is Aug 19, 2025, TBA Not Confirmed.
Last Earnings DateMay 9, 2025
Next Earnings DateAug 19, 2025
Ex-Dividend Date―
Financial Position
Palisade Bio as a current ratio of 3.24, with Debt / Equity ratio of 3.53%
Current Ratio3.24
Quick Ratio3.24
Debt to Market Cap<0.01
Net Debt to EBITDA0.65
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Palisade Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Palisade Bio EV to EBITDA ratio is <0.01, with an EV/FCF ratio of <0.01.
EV to Sales0.00
EV to EBITDA<0.01
EV to Free Cash Flow<0.01
EV to Operating Cash Flow<0.01
Balance Sheet
Palisade Bio has $7.23M in cash and marketable securities with $58.00K in debt, giving a net cash position of -$7.17M billion.
Cash & Marketable Securities$7.23M
Total Debt$58.00K
Net Cash-$7.17M
Net Cash Per Share-$1.50
Tangible Book Value Per Share$1.29
Margins
Gross margin is 100.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin100.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Palisade Bio is $2.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$2.00
Price Target Upside212.50% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-100.00%
EPS Growth Forecast53.88%